S-1 · resale registration
Issued 2025
Proposed maximum
Shares registered
- Filed
- Effective
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 18 of Tvardi Therapeutics, Inc.'s SEC filings and found 3 convertibles, 1 ATM program, 1 shelf registration, 1 S-1 registration and 2 completed offerings on file for TVRD. The latest dilution event on file is ATM sales on Aug 11, 2026. Analysis updated Oct 5, 2026.
Raise routes on file: active ATM + effective shelf + effective S-1 · latest dilution event 84 days ago
The dominant contractual driver and its mechanism, then each further driver ranked.
Aug 11, 2026 · ATM Sale
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Shares outstanding, potential dilution and cash over time
Issued 2025
Proposed maximum
Shares registered
Principal
Conversion Price
Principal
Conversion Price
Principal
Conversion Price
Issued 2026
Total capacity
Sold to date
Issued 2026
Total capacity
Remaining
Gross proceeds
Price per share
Gross proceeds
Price per share
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
DilutionScan ProEvery instrument in full · $59/mo
Covered companies in Biotechnology. All tickers A to Z